SCI Abstract

search
+
Efficacy and safety of abemaciclib plus endocrine therapy versus endocrine therapy alone in HR + and HER2-negative breast cancer; a systematic review and meta-analysis
Efficacy and safety of abemaciclib plus endocrine therapy versus endocrine therapy alone in HR + and HER2-negative breast cancer; a systematic review and meta-analysis
Breast cancer is the most commonly diagnosed cancer worldwide. To evaluate the safety and efficacy of abemaciclib in combi...
Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors
Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors
To improve clinical decision-making in patients with breast cancer receiving CDK 4/6 inhibitors, we examined Duffy status ...
Risk factors for postoperative bleeding following breast cancer surgery: a systematic review and meta-analysis
Risk factors for postoperative bleeding following breast cancer surgery: a systematic review and meta-analysis
Surgical operation serves as a primary approach for addressing cancer of the breast, but it also has potential co...
Compression sleeves for prevention and treatment of breast cancer-related lymphedema: a systematic review and meta-analysis
Compression sleeves for prevention and treatment of breast cancer-related lymphedema: a systematic review and meta-analysis
Compression sleeves are widely used for breast cancer-related lymphedema, but evidence on their effectiveness of preventio...
Lymphovenous bypass for the treatment of secondary lymphedema: A meta-analysis of prospective outcomes
Lymphovenous bypass for the treatment of secondary lymphedema: A meta-analysis of prospective outcomes
Despite the increasing popularity of microsurgical techniques for the treatment of lymphedema, there is a lack of high-lev...
Trimodal therapy is associated with higher overall survival than chemotherapy only in patients with metastatic inflammatory breast cancer
Trimodal therapy is associated with higher overall survival than chemotherapy only in patients with metastatic inflammatory breast cancer
Systemic therapy is standard for metastatic inflammatory breast cancer (MIBC), but the role of locoregional therapy in sur...
Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative database
Assessing the accuracy of inflammatory breast cancer self-reported diagnoses through the metastatic breast cancer project from the count me in initiative database
This study assessed the accuracy of self-reported inflammatory breast cancer (IBC) diagnoses within the Count Me In (CMI) ...
Body composition, chemotherapy dosing and hematologic toxicity among Black and non-Black women being treated for breast cancer
Body composition, chemotherapy dosing and hematologic toxicity among Black and non-Black women being treated for breast cancer
Black women in the United States have higher breast cancer mortality rates compared to women of other races/ethnicities. H...
Tumor biology and access to care and metastatic breast cancer outcomes
Tumor biology and access to care and metastatic breast cancer outcomes
To understand how access to care influences metastatic breast cancer burden (MBC) while accounting for molecular tumor cha...
The impact of breast cancer treatment on sleep disturbance: a systematic review
The impact of breast cancer treatment on sleep disturbance: a systematic review
People receiving treatment for breast cancer often report sleep disturbance. This systematic review explored the prevalenc...
Risk of second non-breast primary cancer in Chinese breast cancer patients with germline pathogenic variants
Risk of second non-breast primary cancer in Chinese breast cancer patients with germline pathogenic variants
The risk of second non-breast primary cancer in Chinese women with breast cancer who carry germline BRCA1/2 pathogenic var...
Changes in compliance with cardiovascular medication after a breast cancer diagnosis: a latent class trajectory analysis using French nationwide data
Changes in compliance with cardiovascular medication after a breast cancer diagnosis: a latent class trajectory analysis using French nationwide data
Managing cardiovascular risk is key for breast cancer survivors, many of whom have pre-existing conditions like hypertensi...
Prognosis and endocrine therapy efficacy in early breast cancer with estrogen receptor low expression
Prognosis and endocrine therapy efficacy in early breast cancer with estrogen receptor low expression
To investigate the prognosis and endocrine therapy (ET) efficacy in patients with estrogen receptor (ER)-low breast cancer...
Inhibition of GPX4 induces the death of p53-mutant triple-negative breast cancer cells
Inhibition of GPX4 induces the death of p53-mutant triple-negative breast cancer cells
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by high rates of tumor protei...
Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently
Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently
Targeted therapies have improved survival in human epidermal growth factor receptor 2 positive breast cancer (HER2 +...
Outcomes of patients with de novo oligometastatic breast cancer treated with curative intent at a single institution
Outcomes of patients with de novo oligometastatic breast cancer treated with curative intent at a single institution
De novo oligometastatic breast cancer (OMBC) is often defined as up to five metastases in two or fewer organs at presentat...
Updated systematic review and meta-analysis: taking the next step in physical activity behavioral interventions for post-treatment breast cancer survivors
Updated systematic review and meta-analysis: taking the next step in physical activity behavioral interventions for post-treatment breast cancer survivors
To provide an updated review of the literature on physical activity (PA) intervention studies, their characteristics, and ...
Trends in postmastectomy radiotherapy for early and locally advanced breast cancer in Switzerland: a population-based cross-sectional and longitudinal analysis
Trends in postmastectomy radiotherapy for early and locally advanced breast cancer in Switzerland: a population-based cross-sectional and longitudinal analysis
Postmastectomy radiotherapy (PMRT) reduces locoregional recurrence and improves survival in high-risk breast cancer (BC), ...
Suppression of breast cancer metastatic behavior by microRNAs targeting EMT transcription factors. A relevant participation of miR-196a-5p and miR-22-3p in ZEB1 expression
Suppression of breast cancer metastatic behavior by microRNAs targeting EMT transcription factors. A relevant participation of miR-196a-5p and miR-22-3p in ZEB1 expression
Metastasis, the leading cause of cancer-associated deaths, is promoted by transcription factors SNAIL, SLUG, ZEB1 and TWIS...
Predicting the likelihood of carrying or pathogenic variants in high-risk Pakistani breast cancer patients
Predicting the likelihood of carrying or pathogenic variants in high-risk Pakistani breast cancer patients
Pathogenic variants (PVs) in BRCA1/2 increase the lifetime risk of breast cancer (BC). Predictive algorithms for BRCA1/2 P...
Omission of multimodal therapy in older adults with high-risk breast cancer
Omission of multimodal therapy in older adults with high-risk breast cancer
Treatment guidelines recommend multimodal therapy for non-metastatic high-risk breast cancer in older adults. However, old...
Effect of chemotherapy timing in triple-negative breast cancer: a real-world evidence study
Effect of chemotherapy timing in triple-negative breast cancer: a real-world evidence study
Triple-negative breast cancer (TNBC) is an aggressive, heterogeneous malignancy with poor prognosis. The optimal timing of...
Invasive lobular breast carcinoma variants; clinicopathological features and patient outcomes
Invasive lobular breast carcinoma variants; clinicopathological features and patient outcomes
An understanding of the differences among the invasive lobular breast carcinoma (ILC) variants is crucial for risk stratif...
Management of ipsilateral breast tumor recurrence after prior breast conservation therapy
Management of ipsilateral breast tumor recurrence after prior breast conservation therapy
Mastectomy is traditionally recommended for local recurrence after breast conservation therapy (BCT), the combination of l...
Social determinants of cardiovascular disease in women with and without breast cancer
Social determinants of cardiovascular disease in women with and without breast cancer
Social determinants of health (SDOH) may impact cardiovascular (CV) risk in women with and without breast cancer (BC). In ...
Timely germline testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study
Timely germline testing after invasive breast cancer promotes contralateral risk-reducing mastectomy and improves survival: an observational retrospective study
To report the rates of risk-reducing surgery (RRS) following germline testing for BRCA1/2 (likely) pathogenic variants (BR...
Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypes
Subtype-specific dysregulation of biogenic amine-related genes and miRNAs in breast cancer: identification of DRD2, HRH2, and HRH4 as potential therapeutic targets in TNBC and HER2+ subtypes
Biogenic amines (BAs) are known to influence tumorigenesis, yet their precise role in breast cancer remains unclear. This ...
Breast magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy and immunotherapy in early triple-negative breast cancer patients: prediction of pathological response and performance of ultrafast sequences
Breast magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy and immunotherapy in early triple-negative breast cancer patients: prediction of pathological response and performance of ultrafast sequences
Immunotherapy with pembrolizumab combined with neoadjuvant chemotherapy allows an improvement of pathological complete res...
Metastatic breast cancer through the Oncotype DX Breast Recurrence Score®: insights from a small cohort study
Metastatic breast cancer through the Oncotype DX Breast Recurrence Score®: insights from a small cohort study
To evaluate the feasibility of obtaining a 21-gene Oncotype DX Breast Recurrence Score® (RS) result from metastatic b...
Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes
Exploring the Nottingham classification: assessing gene expression profiles in breast cancer patients and their association with outcomes
Breast cancer remains a major global health concern due to its high incidence and mortality among women. Accurate prognost...
Load More
format_indent_increase